Quarterly report January - March 31, 2003
Biolight International AB (publ) Quarterly report January 1 - March 31, 2003 · Sales during the first quarter amounted to SEK 457 T (513). · The clinical acceptance within the wound care area has been further strengthened. The geriatric clinic at Östra Sjukhuset, Göteborg, has purchased Biolight® for their treatment of chronic wounds. Company focus in 2003 This year, the company will focus its resources on continuing to establish Biolight® Wound Care in Sweden, and Biolight® Dental Care in Sweden, Germany and Italy. Sales - Q1:2003 Sales during the first quarter amounted to SEK 457 T (513).